Compare Sonida Senior Living, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
USD 1,714 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.44
-66.92%
21.16
Revenue and Profits:
Net Sales:
123 Million
(Quarterly Results - Mar 2026)
Net Profit:
-41 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.75%
0%
-8.75%
6 Months
2.34%
0%
2.34%
1 Year
34.22%
0%
34.22%
2 Years
18.49%
0%
18.49%
3 Years
288.03%
0%
288.03%
4 Years
23.21%
0%
23.21%
5 Years
-19.94%
0%
-19.94%
Sonida Senior Living, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.14%
EBIT Growth (5y)
13.63%
EBIT to Interest (avg)
-0.59
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
4.82
Tax Ratio
0.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.22%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
21.16
EV to EBIT
-70.13
EV to EBITDA
53.53
EV to Capital Employed
37.24
EV to Sales
4.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-53.11%
ROE (Latest)
-66.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 16 Schemes (1.78%)
Foreign Institutions
Held by 24 Foreign Institutions (2.33%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
122.60
97.70
25.49%
Operating Profit (PBDIT) excl Other Income
-8.60
0.90
-1,055.56%
Interest
13.20
9.90
33.33%
Exceptional Items
0.00
-7.80
100.00%
Consolidate Net Profit
-41.50
-30.10
-37.87%
Operating Profit Margin (Excl OI)
-233.10%
-142.10%
-9.10%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 25.49% vs -0.31% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -37.87% vs -10.26% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
381.10
304.30
25.24%
Operating Profit (PBDIT) excl Other Income
26.00
25.30
2.77%
Interest
37.60
33.00
13.94%
Exceptional Items
-12.50
48.50
-125.77%
Consolidate Net Profit
-72.50
-3.30
-2,096.97%
Operating Profit Margin (Excl OI)
-80.70%
-61.70%
-1.90%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 25.24% vs 19.19% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -2,096.97% vs 84.36% in Dec 2024
About Sonida Senior Living, Inc. 
Sonida Senior Living, Inc.
Pharmaceuticals & Biotechnology
Capital Senior Living Corporation is an operator of senior housing communities in the United States. The Company provides senior living services to the elderly, including independent living and assisted living services, and provides home care services at one of its communities. Its continuum of care integrates independent living and assisted living and is bridged by home care through independent home care agencies or its home care agency, sustains residents' autonomy and independence based on their physical and mental abilities. It operates 105 senior housing communities in 22 states with an aggregate capacity of approximately 9000 residents. It also operates one home care agency. It offers assisted living care and services, including personal care services, around the clock staffing, support services and supplemental services.
Company Coordinates 
Company Details
14160 Dallas Pkwy Ste 300 , DALLAS TX : 75254-4383
Registrar Details






